Lower doses of carvedilol in Japanese heart failure patients with reduced ejection fraction could show the potential to be non-inferior to higher doses in US patients: An international collaborative observational study.

Authors: Maeda, Makiko^1,2,3 (AUTHOR) makikom@phs.osaka-u.ac.jp, Humber, Douglas^4,5 (AUTHOR), Hida, Eisuke⁶ (AUTHOR), Ohtani, Tomohito⁷ (AUTHOR), Wang, Guannan⁴ (AUTHOR), Wu, Tong² (AUTHOR), Takeda, Shiori¹ (AUTHOR), Situ, Jacinta N.² (AUTHOR), Hayashi, Jun¹ (AUTHOR), Nonen, Shinpei⁸ (AUTHOR), Takeda, Toshihiro⁹ (AUTHOR), Okamoto, Hiroshi¹⁰ (AUTHOR), Hori, Masatsugu¹¹ (AUTHOR), Sakata, Yasushi⁷ (AUTHOR), Fujio, Yasushi^12,13 (AUTHOR), Tsunoda, Shirley M.^4,5 (AUTHOR) makikom@phs.osaka-u.ac.jp

Source: PLoS ONE. 3/7/2024, Vol. 19 Issue 3, p1-14. 14p.

Subject Terms: *HEART failure patients, *CARVEDILOL, *VENTRICULAR ejection fraction, *FRACTIONS, *ALDOSTERONE antagonists, *ELECTRONIC health records, *JAPANESE people, *IVABRADINE

Company/Entity: OSAKA University , UNIVERSITY of California, San Diego

Anticoagulant Use in High Stroke-Risk Patients With Nonvalvular Atrial Fibrillation

Authors: Nguyen, Hannah K., Humber, Douglas, Checkoway, Harvey, Blanchard, Daniel, Watanabe, Jonathan H.

Source: Consultant pharmacist. 33(9):521-521

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN617313775&indx=1&recIds=ETOCRN617313775

Abstract 13725: The Dose Difference of Carvedilol for Heart Failure Management Between Asian-Americans and Japanese Could Show No Difference in the Improvement of Heart Function

Authors: Maeda, Makiko, Humber, Douglas, Hida, Eisuke, Ohtani, Tomohito, Wang, Guannan, Wu, Tong, Hayashi, Jun, Situ, Jacinta N, Takeda, Shiori, Okamoto, Hiroshi, Takeda, Toshihiro, Hori, Masatsugu, Sakata, Yasushi, Fujio, Yasushi, Tsunoda, Shirley

Source: Circulation (Ovid); November 2022, Vol. 146 Issue: Supplement 1 pA13725-A13725, 1p

Acute and chronic pulmonary emboli.

Authors: Fedullo, Peter, Humber, Douglas

Source: Current Treatment Options in Cardiovascular Medicine; Apr2001, Vol. 3 Issue 2, p139-150, 12p